Not sure who all listened to the conference call the other day. My network access (through phone online) was in/out but did hear some very good points.
When asked about being under $1 in stock price. Company stated that they were doing nothing at this time (almost like they expected it to be above $1 by September) but were not ruling out a possible reverse split or other means to get back up and also OTC BB could be a possibility. My take was once P3 starts, company will have plenty of good news to give out and we'll be above $1 anyway...
Also on Menerba - so far seems totally safe and WORKS like it's supposed to. This is very low risk considering hormone therapy. It was stated even if they only got 2% of the market Menerba could be a BILLION DOLLAR DRUG.
They are looking at partnership based upon performance. Get some $$$ now, then partner could buy in larger once drug is proven.
Everything besides Menerba is on hold right now to preserve capital, which is expected to last til first quarter next year
If anyone taped the whole question/answer on the call, I'd like to have a copy of it to re-listen to, as the one online doesn't have Q & A session.
